Microfluidic T Cell Isolation via Obstacle Arrays and Barcoded Nanoparticles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods, such as flow cytometry, are inadequate for identifying rare antigen-specific T cells in challenging biological samples like tumor infiltrating lymphocytes, where only a few cells of interest are present among a large number of other cells, making it difficult to separate and analyze these cells effectively.
Innovation Solution
A microfluidic device with a separation channel containing an array of obstacles angled relative to the flow direction, which deflects particles of a certain size towards specific walls, allowing for the separation and trapping of antigen-specific T cells using capture channels with trap and outflow regions, and a method involving barcoded nanoparticles to identify and isolate these cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If flow cytometry is used to identify rare antigen-specific T cells, then measurement capability is provided, but measurement precision deteriorates due to the rarity of target cells among large numbers of other cells
Solution Approach 1:
The device segments the separation process into distinct functional zones: a separation channel with obstacle arrays that divide particles by size, and capture channels with trap regions that isolate individual cells. This segmentation enables precise identification of rare T cells by progressively filtering the sample through structured spatial zones rather than attempting simultaneous analysis of all cells.
Solution Approach 2:
The patent introduces barcoded nanoparticles as intermediaries that bind to antigen-specific T cells. These nanoparticles serve as detectable markers that mediate between the rare target cells and the detection system, enabling precise identification without requiring direct observation of the rare cells themselves among the background population.
2Manufacturing precision
If conventional separation methods are used for T cells, then separation capability is provided, but manufacturing precision deteriorates due to difficulty in isolating rare cells
Solution Approach 1:
The device applies local quality by creating regions with different functional properties: the separation channel contains obstacle arrays optimized for size-based sorting, while capture channels contain trap regions with specific geometries for cell retention. Each region is locally optimized for its specific function, enabling high-precision isolation of rare T cells while maintaining overall system throughput through parallel processing capabilities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microfluidic device efficiently separates and traps antigen-specific T cells from other particles, enabling their analysis and identification, even in samples with low cell numbers, and allows for the determination of antigen specificity, facilitating personalized cancer vaccines and T cell immunotherapies.
Implementation Method 1
the array of obstacles is adapted to separate particles having a size at or above a critical size from particles having a size less than the critical size in a flow of a heterogeneous fluid sample through the separation channel
Implementation Method 2
each capture channel comprises a trap region and an outflow region, wherein the width of the trap region is greater than a width at the outflow region
Data Source
AI summary
Disclosed herein are methods and devices for antigen-specific T cell identification or neoantigen identification. Also disclosed herein are devices for separating and isolating antigen-specific T cells or other particles of a certain size from a population of particles of different sizes. Also describe herein are methods and devices for the separation and isolation of barcoded T cells from other nanoparticles containing barcodes for subsequent analysis and further processing of a viable T cell.